| |
| |
|
| Insider
Information: |
Yancopoulos George |
| Relationship: |
Bd. Co-Chair, Presiden... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
868,994 |
|
|
Indirect Shares
|
241,951 |
|
|
| Direct
Value |
$900,729,661 |
|
|
|
Indirect Value
|
$250,787,051 |
|
|
| Total
Shares |
1,110,945 |
|
|
| Total
Value |
$1,151,516,711 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regeneron Pharmaceuticals Inc |
REGN |
Bd. Co-Chair, Presiden... |
2024-06-10 |
868,994 |
2024-06-10 |
241,951 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
147 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
EVP, CSO, & Pres Regn Res Labs |
• • – |
2007-04-09 |
4 |
AS |
$23.80 |
$227,633 |
D/D |
(9,556) |
67,096 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP, CSO, & Pres Regn Res Labs |
• • – |
2007-04-16 |
4 |
AS |
$24.97 |
$9,991 |
D/D |
(400) |
67,096 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP, CSO, & Pres Regn Res Labs |
• • – |
2007-04-09 |
4 |
OE |
$10.56 |
$100,940 |
D/D |
9,556 |
67,196 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP, CSO, & Pres Regn Res Labs |
• • – |
2007-04-16 |
4 |
AS |
$24.40 |
$758,006 |
D/D |
(30,883) |
67,496 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2016-07-21 |
4 |
GD |
$0.00 |
$0 |
I/I |
500,000 |
67,976 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP, CSO, & Pres Regn Res Labs |
• • – |
2007-01-03 |
4 |
D |
$19.69 |
$137,732 |
D/D |
(6,995) |
70,568 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2018-08-03 |
4 |
GD |
$0.00 |
$0 |
I/I |
101,187 |
75,036 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP, CSO, & Pres Regn Res Labs |
• • – |
2007-01-03 |
4 |
OE |
$9.50 |
$285,000 |
D/D |
30,000 |
77,563 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP, CSO, & Pres Regn Res Labs |
• • – |
2003-09-17 |
4 |
S |
$20.70 |
$6,210 |
D/D |
(300) |
80,751 |
|
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP, CSO, & Pres Regn Res Labs |
• • – |
2003-09-17 |
4 |
S |
$20.25 |
$1,013,190 |
D/D |
(49,600) |
81,051 |
|
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2021-01-12 |
4 |
GA |
$0.00 |
$0 |
I/I |
82,108 |
82,108 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
officerTitle |
• • – |
2005-12-27 |
4 |
OE |
$12.75 |
$318,750 |
D/D |
25,000 |
83,950 |
|
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2018-02-16 |
4 |
GD |
$0.00 |
$0 |
I/I |
400,000 |
86,820 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP, CSO, & Pres Regn Res Labs |
• • – |
2007-04-13 |
4 |
D |
$24.60 |
$1,455,361 |
D/D |
(59,161) |
98,379 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2018-12-13 |
4 |
D |
$377.31 |
$47,184,502 |
D/D |
(125,055) |
118,993 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP, CSO, & Pres Regn Res Labs |
• • – |
2003-09-17 |
4 |
D |
$20.95 |
$1,051,669 |
D/D |
(50,199) |
130,651 |
|
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2017-08-03 |
4 |
GD |
$0.00 |
$0 |
I/I |
176,223 |
155,406 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP, CSO, & Pres Regn Res Labs |
• • – |
2007-04-13 |
4 |
OE |
$10.56 |
$955,360 |
D/D |
90,444 |
157,540 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2016-12-16 |
4 |
GA |
$0.00 |
$0 |
I/I |
89,427 |
159,324 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2018-12-13 |
4 |
OE |
$16.80 |
$4,100,006 |
D/D |
244,048 |
167,185 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP, CSO, & Pres Regn Res Labs |
• • – |
2003-09-17 |
4 |
OE |
$4.00 |
$535,568 |
D/D |
126,310 |
172,948 |
|
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2017-08-03 |
4 |
GA |
$0.00 |
$0 |
I/I |
176,223 |
176,223 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Bd. Co-Chair, President & CSO |
• • – |
2024-01-02 |
4 |
AS |
$900.00 |
$15,163,200 |
I/I |
(16,848) |
180,000 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2023-03-23 |
4 |
AS |
$800.59 |
$2,940,374 |
I/I |
(3,656) |
196,848 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2023-02-06 |
4 |
AS |
$800.08 |
$10,552,255 |
I/I |
(13,189) |
200,504 |
0 |
% |
|
147 Records found
|
|
Page 2 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
